300725.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:04):

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production...

Stats
Dzisiejszy wolumen	7.13M
Średni wolumen	7.36M
Kapitalizacja rynkowa	6.58B
EPS	CNY0.199 ( 2023-10-30 )
Następna data zysków	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	35.52
ATR14	CNY0.0670 (0.20%)

Wolumen Korelacja

Długi: 0.33 (neutral)

Krótki: -0.35 (neutral)

Signal:(55.777) Neutral

PharmaBlock Sciences Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaBlock Sciences Korelacja - Waluta/Towar

0.12
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.05
( neutral )

0.11
( neutral )

-0.25
( neutral )

PharmaBlock Sciences Finanse

Annual	2023
Przychody:	CNY1.71B
Zysk brutto:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2023
Przychody:	CNY1.71B
Zysk brutto:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2022
Przychody:	CNY1.59B
Zysk brutto:	CNY725.20M (45.48 %)
EPS:	CNY1.570

FY	2021
Przychody:	CNY1.20B
Zysk brutto:	CNY578.29M (48.13 %)
EPS:	CNY2.46

Financial Reports:

No articles found.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.